KRAS and adenocarcinoma: The frequency of KRAS alterations in pancreatic (92.2%) and colorectal (45.5%) adenocarcinomas was significantly higher than that in the stomach (20.0%) and biliary tract (21.2%) adenocarcinomas (p < 0.01).